New COPD drug safety checked in healthy volunteers
NCT ID NCT06118684
First seen Apr 29, 2026 · Last updated May 07, 2026 · Updated 2 times
Summary
This study looked at how a new medicine called EP395, being developed for COPD, interacts with other common drugs. Healthy adults aged 18 to 55 took part to see how EP395 levels change when taken with verapamil, and how EP395 affects midazolam and digoxin. The goal was to gather safety information for future use in people with COPD.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Trial Consultants AB
Uppsala, 75237, Sweden
Conditions
Explore the condition pages connected to this study.